Announcements Trials
Browse Landscape

Phase

Phase 2 15Phase 1 12Phase 1/2 7Phase 3 6

Status

Recruiting 30Completed 24Unknown 15Not yet recruiting 8Active not recruiting 6Withdrawn 2Terminated 1

Sponsor Class

INDUSTRY 5OTHER 1

Study Type

Interventional 6

Sponsor

Cancer Type

Thoracic 2Other hematologic neoplasm 1Head & Neck 1Breast 1

Conditions

Small Cell Lung Carcinoma 1Recurrence 1Papillomavirus Infections 1Non-Squamous Non-small Cell Lung Cancer 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1Leukemia, Myeloid, Acute 1Breast Cancer Subjects 1

Interventions

Carboplatin 108Cisplatin 98Paclitaxel 79pembrolizumab 70Gemcitabine 60Pemetrexed 49Cyclophosphamide 48Dexamethasone 47Docetaxel 46durvalumab 44Capecitabine 44Radiotherapy 42Doxorubicin 40Lenalidomide 38Specimen Handling 37Nivolumab 37Oxaliplatin 35Rituximab 34Magnetic Resonance Spectroscopy 33Fluorouracil 33Etoposide 32Bevacizumab 32Vincristine 30atezolizumab 29Radiation 28Leucovorin 28Bortezomib 26Prednisone 23Letrozole 23Fulvestrant 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 3 × Active not recruiting × Injections × Clear all
NCT06612151 2026-05-26

A Phase III Study of YL201 in Relapsed Small Cell Lung Cancer

MediLink Therapeutics (Suzhou) Co., Ltd.

Phase 3 Active not recruiting
438 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT05294172 2026-05-08

KL-A167 Injection Combined With Cisplatin and Gemcitabine vs Placebo Combined With Cisplatin and Gemcitabine in the Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

Phase 3 Active not recruiting
295 enrolled
Head & Neck

Nasopharyngeal Carcinoma, Neoplasm Metastasis, Recurrence

NCT05184712 2026-03-04

Phase 3 Clinical Study of AK112 for NSCLC Patients

Akeso

Phase 3 Active not recruiting
322 enrolled
Thoracic

Non-Squamous Non-small Cell Lung Cancer

NCT06449027 2025-10-01

Safety, Efficacy and Pharmacokinetic Behavior of Leuprolide Injectable Emulsion for Premenopausal Breast Cancer Subjects.

Changchun GeneScience Pharmaceutical Co., Ltd.

Phase 3 Active not recruiting
211 enrolled
Breast

Breast Cancer Subjects

NCT04199689 2025-03-25

V503-049

Merck Sharp & Dohme LLC

Phase 3 Active not recruiting
6,033 enrolled

Papillomavirus Infections

NCT05177731 2024-10-03

Venetoclax + Decitabine vs. "7+3" Induction Chemotherapy in Young AML

The First Affiliated Hospital of Soochow University

Phase 3 Active not recruiting
188 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡